Agomelatine : its role in the management of major depressive disorder
Abstract: Circadian rhythm abnormalities, as shown by sleep/wake cycle disturbances, constitute one the most prevalent signs of depressive illness; advances or delays in the circadian phase are documented in patients with major depressive disorder (MDD), bipolar disorder, and seasonal affective diso...
Guardado en:
| Autores principales: | Cardinali, Daniel Pedro, Vidal, María Florencia, Vigo, Daniel Eduardo |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés Inglés |
| Publicado: |
Libertas Academica
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/1630 |
| Aporte de: |
Ejemplares similares
-
Response to Letter to the Editor “On the targets of fluoxetine”
por: Di Rosso, María Emilia, et al.
Publicado: (2025) -
Melatonin agonists for treatment of sleep and depressive disorders
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019) -
Sleep and circadian dysregulation in depressive illness : pharmacological implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Immunomodulatory effects of fluoxetine : a new potential pharmacological action for a classic antidepressant drug?
por: Di Rosso, María Emilia, et al.
Publicado: (2019) -
Essential psychopharmacology of depression and bipolar disorder
por: Stahl, Stephen M.
Publicado: (2000)